Professor, consultant endocrinologist
Bo Abrahamsen is an endocrinologist at Holbæk Hospital in Denmark, and primarily treats patients with osteoporosis, metabolic bone diseases and parathyroid disorders. He attended Medical School in Odense, Experimental Pathology at St. Andrews, UK, and did part of his PhD lab work in Worcester, MA. He was first appointed MSO professor of clinical database studies at the University of Southern Denmark in 2009 and began a permanent clinical professorship there in January 2019. His research interests include fracture- and lifecourse epidemiology, and the safety and efficacy of anti-osteoporosis drugs and supplements. He served on both ASBMR Task Forces on Atypical Femur Fractures and is a Golden Femur award recipient. Professor Abrahamsen is a former member of the Board of Directors of the American Society for Bone and Mineral Research, currently Deputy Editor of JBMR Plus and a member of the Board of the European Calcified Tissue Society. In March 2019, Dr Abrahamsen var also appointed Visiting Professor of Musculoskeletal Epidemiology at NDORMS, University of Oxford.
Osteoporosis - fracture and lifecourse epidemiology - medication safety and efficacy